Therefore, this review aims to provide an overview of the role of APOC3 in regulating cardiometabolic risk, particularly its effects on TG metabolism, and narrow the focus to its specific involvement in diabetes-associated CVDs. Here, APOC3 is linked to diabetes mellitus.